Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-15 Wirk Shaheen Director Other acquisition +263,164 263,164
2025-04-15 Wirk Shaheen Director Grant or award · Stock Option (right to buy) +2,011 2,011
2025-04-15 Shah Sujal Director Grant or award · Stock Option (right to buy) +10,394 10,394
2025-04-15 Shah Sujal Director Grant or award · Stock Option (right to buy) +8,047 8,047
2025-04-15 Larson Jeffrey Leroy SVP, Research & Development Grant or award · Employee Stock Option (right to buy) +16,764 16,764
2025-04-15 Larson Jeffrey Leroy SVP, Research & Development Grant or award · Employee Stock Option (right to buy) +5,364 5,364
2025-04-15 Conn Avi Daniel Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +89,053 89,053
2025-04-15 Alibhai Imran Nizamudin Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +207,881 207,881
2025-04-15 Alibhai Imran Nizamudin Chief Executive Officer Grant or award · Employee Stock Optyion (right to buy) +2,011 2,011
2025-04-15 Alibhai Imran Nizamudin Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +160,940 160,940
2025-02-28 Posner Christopher PRESIDENT AND CEO Sale −583 $4.75 $3K 13,109
2025-02-28 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sale −163 $4.76 $776 7,190
2025-02-04 Posner Christopher PRESIDENT AND CEO Sale −372 $4.72 $2K 13,692
2024-11-04 Posner Christopher PRESIDENT AND CEO Sale −3,668 $0.29 $1K 168,768
2024-08-01 Posner Christopher PRESIDENT AND CEO Sale −4,149 $0.35 $1K 172,436
2024-06-04 Boudreau Helen M Director Grant or award +150,647 150,647
2024-06-04 Boudreau Helen M Director Grant or award · Stock Option (Right to Buy) +195,000 195,000
2024-06-04 von Moltke Lisa Director Grant or award +150,647 183,009
2024-06-04 von Moltke Lisa Director Grant or award · Stock Option (Right to Buy) +195,000 195,000
2024-06-04 Ives Jeffrey L. Director Grant or award +150,647 198,485

Page 3 of 7 · 123 trades